Seeing Is Believing
Currently out of the existing stock ratings of Shanshan Xu, 6 are a BUY (85.71%), 1 are a HOLD (14.29%).
Analyst Shanshan Xu, currently employed carries an average stock price target met ratio of 58.33% that have a potential upside of 25.56% achieved within 70 days.
Shanshan Xu’s has documented 14 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BNTX, BioNTech SE at 09-May-2023.
Analyst best performing recommendations are on BNTX (BIONTECH SE).
The best stock recommendation documented was for BNTX (BIONTECH SE) at 8/2/2021. The price target of $400 was fulfilled within 2 days with a profit of $64.24 (19.13%) receiving and performance score of 95.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
$125
$11.87 (10.49%)
$100
5 days ago
(19-Nov-2024)
3/5 (60%)
$17.45 (16.23%)
14
Buy
$150
$36.87 (32.59%)
$150
6 days ago
(18-Nov-2024)
14/31 (45.16%)
$48.99 (48.50%)
69
Hold
$137
$23.87 (21.10%)
$100
16 days ago
(08-Nov-2024)
4/8 (50%)
$22.54 (19.69%)
95
Hold
$122
$8.87 (7.84%)
$132
18 days ago
(06-Nov-2024)
6/9 (66.67%)
$15.88 (14.96%)
38
Hold
$124
$10.87 (9.61%)
$125
20 days ago
(04-Nov-2024)
5/7 (71.43%)
$13.66 (12.38%)
33
What Year was the first public recommendation made by Shanshan Xu?